Growth differentiation factor-8 transgenic mice
US5994618A · kind A · utility
56Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 5, 1997 |
| Grant date | Nov 30, 1999 |
| Priority date | — |
| Expiry date | Feb 5, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A transgenic mouse whose genome comprises a disruption of the endogenous growth differentiation factor-8 (GDF-8) gene is disclosed. Also disclosed are methods for making such mice. The transgenic mice exhibit a phenotype of increased muscle tissue.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.